
Opinion|Videos|April 2, 2024
Evolving Treatment Landscape in Prostate Cancer
Author(s)Matthew Smith, MD, PhD, Brian Helfand, MD, PhD
Experts on prostate cancer discuss how treatment has evolved over the years, focusing on doublet and triplet therapy and their utility.
Advertisement
Episodes in this series

Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Theranostic therapies expand frontline use in prostate cancer
2
FDA removes warning labels on hormone replacement therapy
3
BioProtect Balloon Spacer shows sustained quality-of-life benefits in long-term study
4
Apalutamide vs Abiraterone Acetate RWE Outcomes in mCSPC
5





















